This seems like a remarkable comparison of products, with so much coming out in favour of BTM.
However, I wasn't sure what to make of the conclusion about economic differences. Seemed like it was a sales-driven article at first take. The authors did not state their postnominals, appointments or employers in the abstract title. Quite unusual in my experience/opinion.
However, a little digging has me much more reassured.
Timothy Olsen looks to be an MD candidate, doing a research paper: https://www.linkedin.com/in/timothy-olsen/
Derek Bell seems to be a senior in plastic and orthopaedic surgeries at Rochester: https://www.urmc.rochester.edu/surgery/plastic/team/
Safi Ali-Khan is listed as a resident physician at Rochester. https://www.linkedin.com/in/safi-ali-khan-a2bb61239/
If this is all genuine info, then it gives a lot more credibility to the abstract IMO.
bj.
The Clinicians Speak, page-863
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
-0.040(1.62%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $2.48 | $2.51 | $2.43 | $1.692M | 690.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 19941 | $2.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.45 | 4032 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |